ALINS 📈 Intrasense - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011179886
ALINS: Medical, Imaging, Software
Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, spin-offs, and research labs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XP-Breast; Myrian XP-Prostate; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams. The company was incorporated in 2004 and is headquartered in Montpellier, France. Web URL: https://www.intrasense.fr
Additional Sources for ALINS Stock
ALINS Stock Overview
| Market Cap in USD | 15m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
ALINS Stock Ratings
| Growth 5y | -29.1% |
| Fundamental | -27.5% |
| Dividend | - |
| Rel. Strength Industry | -1222 |
| Analysts | - |
| Fair Price Momentum | 0.23 EUR |
| Fair Price DCF | - |
ALINS Dividends
No Dividends PaidALINS Growth Ratios
| Growth Correlation 3m | -37.8% |
| Growth Correlation 12m | -61.7% |
| Growth Correlation 5y | -69.2% |
| CAGR 5y | 0.58% |
| CAGR/Mean DD 5y | 0.01 |
| Sharpe Ratio 12m | 0.11 |
| Alpha | -60.65 |
| Beta | 1.39 |
| Volatility | 34.80% |
| Current Volume | 156k |
| Average Volume 20d | 58.9k |
What is the price of ALINS stocks?
As of December 22, 2024, the stock is trading at EUR 0.25 with a total of 156,035 shares traded.
Over the past week, the price has changed by -1.83%, over one month by -4.96%, over three months by -8.84% and over the past year by -26.17%.
As of December 22, 2024, the stock is trading at EUR 0.25 with a total of 156,035 shares traded.
Over the past week, the price has changed by -1.83%, over one month by -4.96%, over three months by -8.84% and over the past year by -26.17%.
Is Intrasense a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Intrasense (PA:ALINS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -27.51 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALINS as of December 2024 is 0.23. This means that ALINS is currently overvalued and has a potential downside of -8%.
Probably not. Based on ValueRay Fundamental Analyses, Intrasense (PA:ALINS) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -27.51 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALINS as of December 2024 is 0.23. This means that ALINS is currently overvalued and has a potential downside of -8%.
Is ALINS a buy, sell or hold?
Intrasense has no consensus analysts rating.
Intrasense has no consensus analysts rating.
What are the forecast for ALINS stock price target?
According to ValueRays Forecast Model, ALINS Intrasense will be worth about 0.3 in December 2025. The stock is currently trading at 0.25. This means that the stock has a potential upside of +4%.
According to ValueRays Forecast Model, ALINS Intrasense will be worth about 0.3 in December 2025. The stock is currently trading at 0.25. This means that the stock has a potential upside of +4%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.2 | -20% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.3 | 4% |